Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Skylight Health Group Inc V.SLHG.H

Alternate Symbol(s):  SLHGF

Skylight Health Group Inc. is a Canada-based healthcare services and technology company. The Company operates a Florida-based primary care health network comprised of physical practices providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company is focused on helping small and independent practices shift from a traditional fee-for... see more

Recent & Breaking News (TSXV:SLHG.H)

CB2 Insights Announces Industry's First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL Brands (Formerly Freedom Leaf Inc.)

GlobeNewswire December 16, 2019

CB2 Insights Completes Full-Scale Platform to Connect Disparate Data Systems

GlobeNewswire December 12, 2019

CB2 Insights Launches Warrant Incentive Program

GlobeNewswire December 11, 2019

CB2 Partners to Grow Medical Cannabis R&D in Colombia

Stockhouse Editorial December 3, 2019

CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia

GlobeNewswire December 3, 2019

Cannabis Data Tech Co. Posts IMPRESSIVE Q3 Results

Dave Jackson November 15, 2019

CB2 Insights to Participate at Piper Jaffray's 31st Annual Healthcare Conference

GlobeNewswire November 14, 2019

CB2 Reports Record Revenue for Q3 2019

Stockhouse Editorial November 8, 2019

CB2 Insights Announces Record Revenue of $4.2 million for the Third Quarter 2019; Sequential Growth of 29%

GlobeNewswire November 8, 2019

CB2 Insights Announces Record Preliminary Unaudited Q3 2019 Revenue of $4.2 Million and Details for Earnings Call

GlobeNewswire November 1, 2019

VIVO and CB2 Insights Enter Technology and Research Partnership

Canada NewsWire October 29, 2019

CB2 Licenses Data Software to UK Cannabis Clinic Network

Stockhouse Editorial September 19, 2019

CB2 Insights Licenses Electronic Data Capture Software to MyAccess Clinics for Use In the UK

GlobeNewswire September 19, 2019

Extraordinary Future - Hottest Tech Investment Opportunities

Jonathon Brown September 18, 2019

CB2 Insights Enters Colombian Market with New Medical Director

Stockhouse Editorial September 3, 2019

CB2 Insights Announces Appointment of Medical Director in Colombia and Enters Market with Cannabis Research Focus

GlobeNewswire September 3, 2019

CB2 Insights Reports Second Quarter Fiscal 2019 Financial Results, Sees Positive Impact from New Acquisitions

GlobeNewswire August 28, 2019

CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019

GlobeNewswire August 20, 2019

CB2 Insights Announces New Appointment to Board of Directors with Medical Cannabis and Capital Markets Executive

GlobeNewswire August 1, 2019

Former Johnson & Johnson Exec. Added to CB2 Board

Stockhouse Editorial July 31, 2019